Hartung HP - Search Results

1

Pushing Forward: Remyelination as the New Frontier in CNS Diseases.

Kremer D, Göttle P, Hartung HP, Küry P. Kremer D, et al. Among authors: hartung hp. Trends Neurosci. 2016 Apr;39(4):246-263. doi: 10.1016/j.tins.2016.02.004. Epub 2016 Mar 7. Trends Neurosci. 2016. PMID: 26964504 Review.

2

Rescuing the negative impact of human endogenous retrovirus envelope protein on oligodendroglial differentiation and myelination.

Göttle P, Förster M, Gruchot J, Kremer D, Hartung HP, Perron H, Küry P. Göttle P, et al. Among authors: hartung hp. Glia. 2019 Jan;67(1):160-170. doi: 10.1002/glia.23535. Epub 2018 Nov 14. Glia. 2019. PMID: 30430656

3

The complex world of oligodendroglial differentiation inhibitors.

Kremer D, Aktas O, Hartung HP, Küry P. Kremer D, et al. Among authors: hartung hp. Ann Neurol. 2011 Apr;69(4):602-18. doi: 10.1002/ana.22415. Ann Neurol. 2011. PMID: 21520230 Review.

4

Mesenchymal stem cell conditioning promotes rat oligodendroglial cell maturation.

Jadasz JJ, Kremer D, Göttle P, Tzekova N, Domke J, Rivera FJ, Adjaye J, Hartung HP, Aigner L, Küry P. Jadasz JJ, et al. Among authors: hartung hp. PLoS One. 2013 Aug 12;8(8):e71814. doi: 10.1371/journal.pone.0071814. eCollection 2013. PLoS One. 2013. PMID: 23951248 Free PMC article.

5

Oligodendroglial maturation is dependent on intracellular protein shuttling.

Göttle P, Sabo JK, Heinen A, Venables G, Torres K, Tzekova N, Parras CM, Kremer D, Hartung HP, Cate HS, Küry P. Göttle P, et al. Among authors: hartung hp. J Neurosci. 2015 Jan 21;35(3):906-19. doi: 10.1523/JNEUROSCI.1423-14.2015. J Neurosci. 2015. PMID: 25609610 Free PMC article.

6

Teriflunomide promotes oligodendroglial differentiation and myelination.

Göttle P, Manousi A, Kremer D, Reiche L, Hartung HP, Küry P. Göttle P, et al. Among authors: hartung hp. J Neuroinflammation. 2018 Mar 13;15(1):76. doi: 10.1186/s12974-018-1110-z. J Neuroinflammation. 2018. PMID: 29534752 Free PMC article.

7

Remyelination in multiple sclerosis: from concept to clinical trials.

Kremer D, Göttle P, Flores-Rivera J, Hartung HP, Küry P. Kremer D, et al. Among authors: hartung hp. Curr Opin Neurol. 2019 Jun;32(3):378-384. doi: 10.1097/WCO.0000000000000692. Curr Opin Neurol. 2019. PMID: 30865009 Review.

8

The Molecular Basis for Remyelination Failure in Multiple Sclerosis.

Gruchot J, Weyers V, Göttle P, Förster M, Hartung HP, Küry P, Kremer D. Gruchot J, et al. Among authors: hartung hp. Cells. 2019 Aug 3;8(8):825. doi: 10.3390/cells8080825. Cells. 2019. PMID: 31382620 Free PMC article. Review.

9

Identification of novel myelin repair drugs by modulation of oligodendroglial differentiation competence.

Manousi A, Göttle P, Reiche L, Cui QL, Healy LM, Akkermann R, Gruchot J, Schira-Heinen J, Antel JP, Hartung HP, Küry P. Manousi A, et al. Among authors: hartung hp. EBioMedicine. 2021 Mar;65:103276. doi: 10.1016/j.ebiom.2021.103276. Epub 2021 Mar 10. EBioMedicine. 2021. PMID: 33714029 Free PMC article.

10

The cyclin-dependent kinase inhibitor p57kip2 is a negative regulator of Schwann cell differentiation and in vitro myelination.

Heinen A, Kremer D, Göttle P, Kruse F, Hasse B, Lehmann H, Hartung HP, Küry P. Heinen A, et al. Among authors: hartung hp. Proc Natl Acad Sci U S A. 2008 Jun 24;105(25):8748-53. doi: 10.1073/pnas.0802659105. Epub 2008 Jun 11. Proc Natl Acad Sci U S A. 2008. PMID: 18550808 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,136 results

Search Page

Filters